Zingerone attenuates concanavalin A-induced acute liver injury by restricting inflammatory responses
- PMID: 39305891
- DOI: 10.1016/j.intimp.2024.113198
Zingerone attenuates concanavalin A-induced acute liver injury by restricting inflammatory responses
Abstract
Autoimmune hepatitis (AIH), an immune-mediated liver injury, plays an important role in the development and pathogenesis of several liver diseases. However, therapeutic alternatives for the treatment of AIH remain limited. Zingerone (ZIN) is a natural non-toxic phenolic compound extracted from ginger that possesses various pharmacological activities. Thus, this study aimed to investigate the effect of ZIN on AIH using a mouse model of acute liver injury induced by concanavalin A (Con A). To establish liver injury, C57BL/6J mice were intraperitoneally administered ZIN, followed by 20 mg/kg Con A after 3 h. Thereafter, the liver and serum were collected for analysis. The results revealed that ZIN pretreatment significantly suppressed the elevation of liver injury markers induced by Con A exposure and improved the survival of mice. Additionally, ZIN significantly ameliorated liver histopathological injury, hepatocyte apoptosis, and oxidative stress. Notably, ZIN inhibited hepatic M1 macrophage polarization and decreased the expression of M1 macrophage-associated pro-inflammatory genes and cytokines, including interleukin-1β (IL-1β), IL-12, IL-6, and tumor necrosis factor-α (TNF-α). Western blotting analysis indicated that ZIN inhibited the phosphorylation of extracellular receptor kin, c-Jun N-terminal kinase, and p65 in vitro. Taken together, these results suggest that ZIN exerts a protective effect in the Con A-induced acute liver injury model by inhibiting M1 macrophage polarization and suppressing NF-κB, mitogen-activated protein kinase, and interferon regulatory factor signaling pathways. This highlights the possibility of using ZIN as a safe drug for the treatment of liver injury and provides a novel therapeutic direction for clinical studies on liver diseases.
Keywords: Autoimmune hepatitis; Concanavalin A; Ginger extract; Liver injury; M1 macrophage; Zingerone.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Cucurbitacin IIb mitigates concanavalin A-induced acute liver injury by suppressing M1 macrophage polarization.Int Immunopharmacol. 2025 Feb 6;147:113964. doi: 10.1016/j.intimp.2024.113964. Epub 2025 Jan 3. Int Immunopharmacol. 2025. PMID: 39755110
-
Zingerone attenuates vancomycin-induced hepatotoxicity in rats through regulation of oxidative stress, inflammation and apoptosis.Life Sci. 2020 Oct 15;259:118382. doi: 10.1016/j.lfs.2020.118382. Epub 2020 Sep 6. Life Sci. 2020. PMID: 32898532
-
Corilagin Ameliorates Con A-Induced Hepatic Injury by Restricting M1 Macrophage Polarization.Front Immunol. 2022 Jan 13;12:807509. doi: 10.3389/fimmu.2021.807509. eCollection 2021. Front Immunol. 2022. PMID: 35095894 Free PMC article.
-
Antimalarial agent artesunate protects Concanavalin A-induced autoimmune hepatitis in mice by inhibiting inflammatory responses.Chem Biol Interact. 2017 Aug 25;274:116-123. doi: 10.1016/j.cbi.2017.07.012. Epub 2017 Jul 13. Chem Biol Interact. 2017. PMID: 28712788
-
Pathogenesis of Concanavalin A induced autoimmune hepatitis in mice.Int Immunopharmacol. 2022 Jan;102:108411. doi: 10.1016/j.intimp.2021.108411. Epub 2021 Dec 8. Int Immunopharmacol. 2022. PMID: 34891001 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous